Henlius

Henlius is a global biopharmaceutical company headquartered in Shanghai, China. Founded in 2010, Henlius focuses on developing and commercializing high-quality, affordable, and innovative biologic medicines for patients worldwide, specializing in oncology, autoimmune diseases, and ophthalmic diseases. They have built an integrated biopharmaceutical platform with core capabilities in research and development, manufacturing, and commercialization, with a strong emphasis on innovation. As a result, Henlius has a robust product pipeline encompassing over 50 molecules.

To date, Henlius has six products approved in China and three products approved in overseas markets, with 24 indications approved worldwide. They are actively expanding their presence in major markets and emerging markets through collaborations with overseas partners. Henlius has established a global innovation center and commercial manufacturing facilities certified by China, the EU, and the U.S. GMP. In addition to its biosimilar products, Henlius is also developing innovative therapies, including its proprietary anti-PD-1 mAb (H药-汉斯状®). This product is a pioneer in its field, being the world's first anti-PD-1 mAb approved for first-line treatment of SCLC.

Henlius offers a comprehensive benefits package for its employees, demonstrating their commitment to attracting, empowering, and retaining top talent. While the specific details are not explicitly stated on the website, Henlius emphasizes its talent philosophy of "attracting people with visions, engaging people with rewards, cultivating people with challenges, and assessing people with performance." This suggests a strong focus on employee development and career progression, alongside competitive compensation and perks.

Henlius is a global biopharmaceutical company committed to providing high-quality, affordable, and innovative biologic medicines for patients worldwide, focusing on oncology, autoimmune diseases, and ophthalmic diseases. They strive to improve patients' lives by offering timely access to these therapies.

Henlius promotes a culture that emphasizes honesty, integrity, and preventative measures against corruption. They are committed to fostering a healthy, stable, and sustainable development of the company and strive to attract, engage, empower, and retain talent through their talent philosophy of "attracting people with visions, engaging people with rewards, cultivating people with challenges and assessing people with performance".

Henlius emphasizes a culture of attracting, engaging, empowering, and retaining talent by valuing diversity, equity, and inclusion. This approach is reflected in their talent philosophy of “attracting people with visions, engaging people with rewards, cultivating people with challenges and assessing people with performance,” which aims to create a dynamic and inclusive work environment where all individuals can thrive.